BriaCell Therapeutics Corp. (BCTXL)
↓ Download CSVKey ratios (FY2025)
-151.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Income | -$27.20M | -$33.33M | -$23.27M | -$15.29M | -$6.98M |
| Net Income | -$26.31M | -$4.79M | -$20.30M | -$26.84M | -$13.82M |
| EPS (Diluted) | $-62.19 | $-43.68 | $-1.30 | $-1.73 | $-3.06 |
| Total Assets | $21.65M | $5.87M | $27.16M | $42.58M | $58.04M |
| Shareholders' Equity | $17.33M | -$2.68M | -$3.78M | $10.33M | — |
| Cash & Equivalents | $10.49M | $862.1K | $21.25M | $41.04M | $57.27M |
| Operating Cash Flow | -$28.17M | -$24.13M | -$23.74M | -$12.48M | -$7.75M |
| Capital Expenditures | — | $456.8K | — | — | — |
| Shares Outstanding | 1.88M | 121.9K | 15.98M | 15.52M | 15.27M |